Amyris, Inc. is a company within the Biotechnology category. Amyris, Inc. is a synthetic biology company that transforms sugar into sustainable molecules through yeast fermentation. Originally focused on biofuels, the company shifted to producing high-value ingredients for the cosmetics, fragrance, and health industries before undergoing a major structured bankruptcy and reorganization in 2023.
Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, CA.
Amyris, Inc. is part of Independent Post Restructuring.
Amyris, Inc. is rated Contender on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Amyris, Inc. is Moderate. Significant factual deltas detected.
AI models classify Amyris, Inc. as a Misread. Visible but inaccurate.
Amyris, Inc. appeared in 5 of 8 sampled buyer-intent queries (63%). Amyris is well-represented in high-intent financial and biotech queries but is losing visibility in consumer-facing 'clean beauty' searches as its brands are sold off.
AI will reliably identify the company's scientific roots and its massive 2023 bankruptcy. However, it may struggle to distinguish between the 'old' Amyris (consumer-facing conglomerate) and the 'new' Amyris (restructured B2B entity). Key gap: The disconnect between Amyris as a high-growth consumer house (pre-2023) and its current state as a restructured B2B technology firm.
Of 5 key facts verified about Amyris, Inc., 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Confusion regarding which consumer brands (Biossance, Pipette, JVN) are still owned by Amyris versus those sold during bankruptcy proceedings.
Buyers turn to Amyris, Inc. for Traditional Petrochemical Synthesis: Laboratories manually synthesizing chemical compounds using traditional petroleum-based methods., Specialized Chemical Agencies: Contracting specialized chemistry firms to develop high-cost, low-yield batches of rare ingredients., Status Quo Sourcing: Continuing to use non-sustainable or high-cost traditional ingredients despite supply chain instability., among 3 documented problem areas.
Buyers evaluating Amyris, Inc. typically ask AI models about "synthetic biology companies california", "sustainable squalane production", "best clean beauty skincare brands 2024", and 3 similar queries.
Amyris, Inc.'s main competitors are Genomatica (Geno), Ginkgo Bioworks, Zymergen. According to AI models, these are the brands most frequently named alongside Amyris, Inc. in buyer-intent queries.
Amyris, Inc.'s core products are Bio-based squalane, Hemisqualane, Reb M sweetener, fragrance molecules, and Lab-to-Market technology platform..
Amyris, Inc. uses B2B Licensing and Ingredient Supply Agreements.
Amyris, Inc. serves Cosmetics, Fragrance, Health & Nutrition, Pharmaceuticals.
Amyris, Inc. Patented yeast strains that can produce complex molecules at scale more efficiently than traditional extraction.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Archetype: Misread
https://optimly.ai/brand/amyris
Last analyzed: April 10, 2026
Founded: 2003
Headquarters: Emeryville, California, USA